|
Volumn 18, Issue 16, 2010, Pages 6149-6155
|
Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents
|
Author keywords
3,5 Diaryl pyrazole derivatives; Anti inflammatory activity; Anticancer activity; Diphenolase inhibitors; Polyphenol oxidase; Rohitukine; Tyrosinase
|
Indexed keywords
2 (2 HYDROXYMETHYL 1 METHYL PYRROLIDIN 3 YL) 3,5 DIMETHOXY 6 [5 (2 METHOXYPHENYL) 1H PYRAZOL 3 YL]PHENOL;
2 (2 HYDROXYMETHYL 1 METHYLPYRROLIDIN 3 YL) 3,5 DIMETHOXY 6 (5 O TOLYL 1H PYRAZOL 3 YL)PHENOL;
2 (2 HYDROXYMETHYL 1 METHYLPYRROLIDIN 3 YL) 3,5 DIMETHOXY 6 (5 P TOLYL 1H PYRAZOL 3 YL)PHENOL;
2 (2 HYDROXYMETHYL 1 METHYLPYRROLIDIN 3 YL) 3,5 DIMETHOXY 6 [5 (4 METHOXYPHENYL) 1H PYRAZOL 3 YL]PHENOL;
2 [5 (2 BROMOPHENYL) 1H PYRAZOL 3 YL] 6 (2 HYDROXYMETHYL 1 METHYLPYRROLIDIN 3 YL] 3,5 DIMETHOXYPHENOL;
2 [5 (2 CHLORO 4 NITROPHENYL) 1H PYRAZOL 3 YL] 6 (2 HYDROXYMETHYL 1 METHYLPYRROLIDIN 3 YL) 3,5 DIMETHOXYPHENOL;
2 [5 (2 CHLOROPHENYL) 1H PYRAZOL 3 YL] 6 (2 HYDROXYMETHYL 1 METHYLPYRROLIDIN 3 YL) 3,5 DIMETHOXYPHENOL;
2 [5 (2 FLUOROPHENYL) 1H PYRAZOL 3 YL] 6 (2 HYDROXYMETHYL 1 METHYLPYRROLIDIN 3 YL) 3,5 DIMETHOXYPHENOL;
2 [5 (2,4 DICHLOROPHENYL) 1H PYRAZOL 3 YL] 6 (2 HYDROXYMETHYL 1 METHYLPYRROLIDIN 3 YL) 3,5 DIMETHOXYPHENOL;
2 [5 (2,4 DIMETHOXYPHENYL) 1H PYRAZOL 3 YL] 6 (2 HYDROXYMETHYL 1 METHYLPYRROLIDIN 3 YL) 3,5 DIMETHOXYPHENOL;
2 [5 (3 BROMOPHENYL) 1H PYRAZOL 3 YL] 6 (2 HYDROXYMETHYL 1 METHYLPYRROLIDIN 3 YL) 3,5 DIMETHOXYPHENOL;
2 [5 (3 CHLOROPHENYL) 1H PYRAZOL 3 YL] 6 (2 HYDROXYMETHYL 1 METHYLPYRROLIDIN 3 YL) 3,5 DIMETHOXYPHENOL;
2 [5 (4 BROMOPHENYL) 1H PYRAZOL 3 YL] 6 (2 HYDROXYMETHYL 1 METHYLPYRROLIDIN 3 YL) 3,5 DIMETHOXYPHENOL;
2 [5 (4 CHLOROPHENYL) 1H PYRAZOL 3 YL] 6 (2 HYDROXYMETHYL 1 METHYLPYRROLIDIN 3 YL) 3,5 DIMETHOXYPHENOL;
2 [5 (4 FLUOROPHENYL) 1H PYRAZOL 3 YL] 6 (2 HYDROXYMETHYL 1 METHYLPYRROLIDIN 3 YL) 3,5 DIMETHOXYPHENOL;
8 [2 (HYDROXYMETHYL) 1 METHYLPYRROLIDIN 3 YL] 5,7 DIMETHOXY 2 PHENYL 4H CHROMEN 4 ONE;
ALCOHOL;
ANTIINFLAMMATORY AGENT;
ANTINEOPLASTIC AGENT;
DEXAMETHASONE;
FLAVOPIRIDOL;
HYDRAZINE;
INTERLEUKIN 6;
OXYGENASE INHIBITOR;
PYRAZOLE DERIVATIVE;
PYRROLIDINE DERIVATIVE;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
ANTIINFLAMMATORY ACTIVITY;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BREAST CANCER;
CANCER CELL CULTURE;
COLON CANCER;
COMBINATORIAL CHEMISTRY;
COMPETITIVE INHIBITION;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG BINDING;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
IC 50;
INFRARED SPECTROSCOPY;
LEUKEMIA CELL LINE;
LUNG CANCER;
MASS SPECTROMETRY;
PROMYELOCYTIC LEUKEMIA;
PROSTATE CANCER;
PROTON NUCLEAR MAGNETIC RESONANCE;
STRUCTURE ACTIVITY RELATION;
AGARICALES;
ANTI-INFLAMMATORY AGENTS;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
CYTOKINES;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMANS;
MODELS, MOLECULAR;
MONOPHENOL MONOOXYGENASE;
NEOPLASMS;
PYRAZOLES;
|
EID: 77955470505
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2010.06.046 Document Type: Article |
Times cited : (69)
|
References (43)
|